Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer

• Cristian Rodriguez-Aguayo,
• Paloma del C Monroig,
• Roxana S. Redis,
• Emine Bayraktar,
• Maria I. Almeida,
• Cristina Ivan,
• Enrique Fuentes-Mattei,
• Mohammed H. Rashed,
• Arturo Chavez-Reyes,
• Bulent Ozpolat,
• Rahul Mitra,
• Anil K. Sood,
• George A. Calin,
• Gabriel Lopez-Berestein

Affiliations

Cristian Rodriguez-Aguayo

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Paloma del C Monroig

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Roxana S. Redis

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Emine Bayraktar

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Maria I. Almeida

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Cristina Ivan

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Enrique Fuentes-Mattei

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Mohammed H. Rashed

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Arturo Chavez-Reyes

Center for Research and Advanced Studies, National Polytechnic Institute (CINVESTAV del IPN)

Bulent Ozpolat

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Rahul Mitra

Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center

Anil K. Sood

Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center

George A. Calin

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center

Gabriel Lopez-Berestein

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center